Montelukast Prescribing at THE MAGNA GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,517
Total Quantity
68.2K
NHS Cost
£4.0K
vs National Avg
+267.6%
THE MAGNA GROUP PRACTICE prescribed 2,517 items of Montelukast over the last 12 months at a cost of £3,951 to the NHS. This is 267.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
221
Jun 2026
218
Jun 2026
235
Jun 2026
226
Jun 2026
211
Jun 2026
212
Jun 2026
202
Jun 2026
195
Jun 2026
217
Jun 2026
183
Jun 2026
197
Jun 2026
200
Prescribing Details
| Total Items | 2,517 |
|---|---|
| Total Quantity | 68,225 |
| Total NHS Cost | £3,951 |
| Presentations | 5 different forms |
| vs National Average | +267.6% |
Montelukast Prescribing Comparison
| This practice | 2,517 items |
|---|---|
| National average per practice | 685 items |
| Difference | +267.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.